A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects
Clinical trial NCT06126562 · COMPLETED
Trial details
- NCT number
- NCT06126562
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-31
- Primary completion
- 2023-11-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.